Alexis Meroney

Alexis Meroney

Associate Director, Business Development

Business Development
About

Alexis Meroney drives growth and innovation in the drug development and manufacturing sector, leveraging more than five years of business experience to identify and pursue new opportunities and build long-term relationships with clients and partners. 

Alexis has a proven track record of delivering well-qualified sales leads, managing complex projects, and communicating effectively with diverse stakeholders. She holds a degree from Stockton University.

Quotient Sciences Translational Pharmaceutics
Translational Pharmaceutics, Drug Product Optimization, First-in-Human, Human ADME

Translational Pharmaceutics® Integrated Drug Development Info Sheet

10 March 2025 Download Now

Latest news from Quotient Sciences

More News
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline By: Dr. Andrew Lewis
Read More
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More